-

Cutera® Appoints Chris House as Chief Technology Officer and Charles Hunt as Vice President of Design & Experience, Reinforcing Commitment to Innovation

Powering the next phase of innovation and design with a focus on future-forward technology, product development, and clinical impact.

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., a leading provider of aesthetic and dermatological solutions, announces today the appointments of Chris House as Chief Technology Officer and Charles Hunt as Vice President of Design and Experience. These strategic appointments underscore Cutera’s commitment to next-generation solutions and customer-centered product development.

These strategic appointments underscore Cutera’s commitment to next-generation solutions and customer-centered product development.

Share

As Chief Technology Officer, Chris House will lead Cutera’s global technology and product development strategy, focusing on advancing the company’s product pipeline with transformative solutions. Mr. House brings over 25 years of experience in research and development, building, launching, and scaling successful consumer products, SaaS platforms, and AI-enabled solutions across healthcare and enterprise environments. He has led large, global engineering teams, driving end-to-end innovation from concept through commercialization.

Most recently serving as CTO at HealthAxis, Mr. House led enterprise-wide AI strategy, cloud transformation, and the development of advanced healthcare platforms designed to improve clinical outcomes and operational efficiency. His leadership spanned global teams of hundreds of engineers and product leaders, delivering strategic innovation at scale.

“Chris’s appointment represents a pivotal step in Cutera’s evolution, as we continue to raise the bar for the industry,” said Ron Louks, Interim CEO, Cutera. “His expertise will help us rethink and advance our product portfolio, developing treatment solutions that are more intelligent, integrated, and aligned with the goals of our providers and their patients.”

As Vice President of Design & Experience, Charles Hunt will lead Cutera’s global user experience strategy, with a focus on product design, optimization, and enhancing the company’s digital ecosystem to better serve Cutera’s customers. Mr. Hunt brings over 25 years of experience leading multidisciplinary design, marketing, and innovation teams across healthcare and consumer technology. He has a strong track record of translating user insights into impactful product experiences, driving adoption and market success.

Prior to joining Cutera, Mr. Hunt served as VP of User Experience at NantHealth, where he led the modernization of design systems across multiple product lines, improving usability and enhancing outcomes for over half a million enterprise users. He has also held leadership roles at BlackBerry, HTC, and Sony Ericsson, contributing to globally recognized, award-winning product designs.

“Charles brings a unique ability to connect user needs with business strategy,” said Ron Louks, Interim CEO, Cutera. “His leadership will help define a more unified and thoughtful experience across our portfolio, ensuring every interaction with Cutera is purposeful, intuitive, and designed to better support practices and clinics worldwide.”

In addition to these strategic appointments, Cutera is strengthening its research and development organization as part of a broader commitment to advancing innovation across the company. Together, Mr. House and Mr. Hunt will partner closely to drive the development of modern, user-centered solutions, bringing a new perspective to how Cutera designs, builds, and delivers technology that elevates the aesthetics and dermatology industry.

“Cutera is entering an exciting next phase as a global company,” said Brent Hauser, Chief Commercial Officer, Cutera. “By combining results-driven treatments with a strong product and clinical foundation, we have an opportunity to deliver high-performance devices that create real value for providers and patients alike.”

These leadership appointments signal Cutera’s focus on building for the future with a renewed emphasis on technology, design, and customer-centricity to deliver meaningful advancements worldwide.

For further information on how Cutera is shaping dermatology and aesthetics, interested providers can visit www.cutera.com.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit Cutera.com.

Contacts

Media and Industry:
Erica Dement, Executive Director of North America Marketing
edement@cutera.com

Cutera, Inc.

Details
Headquarters: Brisbane, CA
CEO: Ron Louks
Employees: 450
Organization: PRI

Release Versions

Contacts

Media and Industry:
Erica Dement, Executive Director of North America Marketing
edement@cutera.com

Social Media Profiles
More News From Cutera, Inc.

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...
Back to Newsroom